penalites

perrigo

Pharma

IRS knocks Perrigo for $873M in unpaid royalties

Think $1.9 billion in back taxes looks bad? Perrigo was knocked Monday for $873 million in unpaid royalties as part of its sale of MS drug Tysabri.

Kyle Blankenship Apr 30, 2019 12:38pm

Pill pack

Reckitt Benckiser hit with double dose of problems in Korea, Australia

May 2, 2016 3:39am